Announcements Trials
Browse Landscape

Phase

Phase 2 21Phase 4 18Phase NA 13Phase 3 8Phase 1 3Phase 2/3 2Phase EARLY_PHASE1 1

Status

Unknown 1Suspended 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1Pain 1Neoplasms 1Cancer Pain 1Agnosia 1

Interventions

Cisplatin 54Cyclophosphamide 42Fluorouracil 41Oxaliplatin 36Capecitabine 35Docetaxel 34Gemcitabine 32Drug Therapy 32Radiotherapy 31Paclitaxel 25Dexamethasone 23Carboplatin 23Leucovorin 21Etoposide 17Doxorubicin 17Cytarabine 17apatinib 16Methotrexate 16Magnetic Resonance Spectroscopy 14Radiation 13Epirubicin 13Busulfan 13Bevacizumab 13Surgical Procedures, Operative 12Neoadjuvant Therapy 12Letrozole 12Decitabine 12Saline Solution 11Irinotecan 11venetoclax 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × OTHER × Acetaminophen × Clear all
NCT05597878 2026-05-26

Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy

Wake Forest University Health Sciences

Phase 2/3 Suspended
100 enrolled
Genitourinary

Agnosia, Prostatic Neoplasms

NCT00525967 2007-09-06

Switching From Morphine to Oral Methadone Plus Acetaminophen in the Treatment of Cancer Pain

Faculdade de Medicina do ABC

Phase 2/3 Unknown
50 enrolled

Cancer Pain, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡